Dillaha Larry 4
4 · Insys Therapeutics, Inc. · Filed May 16, 2013
Insider Transaction Report
Form 4
Dillaha Larry
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2013-05-14+100,000→ 100,000 totalExercise: $10.89Exp: 2023-05-13→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017.